Source: Virtual Congress 2021 – Deep phenotyping of obstructive diseases for precision medicine



Rating:

Share or cite this content

Citations should be made in the following way:
W. Labaki (Ann Arbor, United States of America), C. Hatt (Minneapolis, United States of America), A. Bell (Ann Arbor, United States of America), C. Galban (Ann Arbor, United States of America), E. Kazerooni (Ann Arbor, United States of America), S. Murray (Ann Arbor, United States of America), J. Curtis (Ann Arbor, United States of America), F. Martinez (New York, United States of America), I. Barjaktarevic (Los Angeles, United States of America), R. Barr (New York, United States of America), R. Bowler (Denver, United States of America), A. Comellas (Iowa City, United States of America), C. Cooper (Los Angeles, United States of America), D. Couper (Chapel Hill, United States of America), G. Criner (Philadelphia, United States of America), M. Dransfield (Birmingham, United States of America), N. Hansel (Baltimore, United States of America), E. Hoffman (Iowa City, United States of America), R. Kanner (Salt Lake City, United States of America), J. Krishnan (Chicago, United States of America), V. Ortega (Winston-Salem, United States of America), R. Paine Iii (Salt Lake City, United States of America), P. Woodruff (San Francisco, United States of America), M. Han (Ann Arbor, United States of America). Association between functional small airways disease and 3-year change in emphysema in the SPIROMICS cohort. 1283

Member's Comments

No comment yet.

Related content which might interest you: Eosinophilic inflammation and lung function decline in a long-term follow-up of a large population-based asthma cohort Source: International Congress 2018 – Asthma in children and adults: long-term aspects Year: 2018 Association between chronic obstructive pulmonary disease and endometriosis: a population-based cohort study Source: Virtual Congress 2020 – Prevalence and incidence of chronic lung diseases Year: 2020 Lung core-predominant emphysema is associated with higher symptom burden in COPD: analysis of the COPDGene cohort Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes Year: 2017 The relationship between presence of small airways disease and baseline characteristics of asthma and COPD patients Source: International Congress 2016 – Monitoring airway diseases with different tools Year: 2016 Functional single nucleotide polymorphisms of the CCL5 gene and nonemphysematous phenotype in COPD patients Source: Eur Respir J 2008; 32: 372-378 Year: 2008 Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort Source: International Congress 2019 – Basic research of airway diseases Year: 2019 Association of inflammatory biomarkers with comorbidity in chronic obstructive pulmonary disease – results from the COSYCONET cohort Source: International Congress 2017 – Current challenges in COPD evaluation Year: 2017 Association between emphysema, exacerbations and mortality in the COPDGene and SPIROMICS cohorts Source: International Congress 2017 – COPD management: new findings from large studies Year: 2017 Association of asthma diagnosis with chronic airflow obstruction: a multi-site cross-sectional study Source: Virtual Congress 2021 – Asthma burden and management I Year: 2021 Lung cancer in combined pulmonary fibrosis and emphysema: a large retrospective cohort analysis Source: ERJ Open Res, 6 (4) 00521-2020; 10.1183/23120541.00521-2020 Year: 2020 Characteristics of subjects susceptible to exacerbation-like respiratory events in a population-based cohort: Canadian cohort obstructive lung disease (CanCOLD) study Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014 Studying the natural history of lung function in COPD patients in the 4-year UPLIFT® trial Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD Year: 2010 Lung function decline in adult asthmatics. A 10-year follow-up Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Early markers of cystic fibrosis structural lung disease: follow-up of the ACFBAL cohort Source: Eur Respir J, 55 (4) 1901694; 10.1183/13993003.01694-2019 Year: 2020 Association between lung function decline and occupational exposures in patients with COPD Source: International Congress 2017 – Shared exposures related to interstitial disease and airflow obstruction Year: 2017 Longitudinal changes in the nature, severity and frequency of COPD exacerbations Source: Eur Respir J 2003 Dec 01;22(6):931-936 Year: 2003 Disease characteristics and outcomes in a Swedish cohort of patients with pulmonary fibrosis (PF) Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018 CF disease progress regarding lung symptoms – a cohort study Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know? Year: 2007 1-year prospective study in severe COPD patients: marker of inflammation, lung function and radiologic evaluation Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Association between airway inflammation, disease control and lung function parameters in asthma Source: Annual Congress 2010 - Cough, airway hyperresponsiveness and asthma control Year: 2010